J-TARGET,Japanese Telmisartan Study for Antihypertensive Good Effect in Long Term Observation

Boehringer Ingelheim

Status: Completed

Conditions: Hypertension

Treatments: Drug: Telmisartan

Study type: Observational

Funder types: Industry

Identifiers

NCT00659581

502.511

Details and patient eligibility

About

The primary objective of this post marketing survey is to prospectively investigate patients with hypertension treated with Micardis Tablets (hereinafter "this drug") in routine clinical settings for 3 years in order to determine the following:

1. Adverse events and adverse drug reactions under long-term use
2. Blood pressure measurements during the survey period
3. Determination of the incidence of cerebrovascular and cardiovascular events under use of this drug in routine clinical settings
4. Patient's lifestyle and background factors that are considered to affect the occurrence of cerebrovascular and cardiovascular events

Enrollment: 21,471 patients

Sex: All

Ages: 20 to 100 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

Hypertension patients unadministered Micardis.

Exclusion criteria

1. Patients with a history of hypersensitivity to any ingredient of this product.
2. Pregnant woman or possibly pregnant woman
3. Patients with extremely poor bile secretion or patients with serious hepatic disorder

Trial design

21,471 participants in 1 patient group

Patients with hypertension

Treatment:

Drug: Telmisartan